Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry
Author:
Affiliation:
1. Department of Internal Medicine, Kalmar County Hospital, Kalmar, Sweden;
2. Department of Oncology, Lund University, Lund, Sweden; and
3. Department of Oncology, Skane University Hospital, Lund, Sweden
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/124/10/1570/1379431/1570.pdf
Reference24 articles.
1. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues.;Swerdlow,2008
2. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.;Vose;J Clin Oncol,2008
3. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d’Etude des Lymphomes Agressives).;Coiffier;Ann Oncol,1990
4. Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350.;Mahadevan;Cancer,2013
5. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors.;Mak;J Clin Oncol,2013
Cited by 308 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study;The Lancet Haematology;2024-09
2. Peripheral T-cell lymphoma: From biology to practice to the future;Cancer Treatment Reviews;2024-09
3. Optimizing Frontline Treatment for PTCL;Clinical Lymphoma Myeloma and Leukemia;2024-09
4. Real World Data on Efficacy and Safety of EPOCH in T-Cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2024-09
5. Application patterns and outcomes of hematopoietic stem cell transplantation in peripheral T-cell lymphoma patients: a multicenter real-world study in China;Experimental Hematology & Oncology;2024-08-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3